The Law Firm of Levi & Korsinsky, LLP Announces Investigation of American Medical Alert Corp.

Show Health and Fitness Publications

Thu, October 13, 2011

[ Thu, Oct 13th 2011 ] - Market Wire

Amica Mature Lifestyles to Announce First Quarter .. esults and Host Conference Call November 14, 2011

[ Thu, Oct 13th 2011 ] - Market Wire

Vanguard Health Systems Appoints Former Tennessee Governor to Board of Directors

[ Thu, Oct 13th 2011 ] - Market Wire

AMRI Appoints New President, India Operations and .. of Project Management a" Pharmaceutical Services

[ Thu, Oct 13th 2011 ] - Market Wire

Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger

[ Thu, Oct 13th 2011 ] - Market Wire

Mercka?s ISENTRESS® (raltegravir) in Combination .. cal and Immunological Efficacy Versus the Efavire

[ Thu, Oct 13th 2011 ] - Market Wire

Micromet Obtains FDA Feedback on Registration Strategy for Blinatumomab in Relapsed/Refractory ALL

[ Thu, Oct 13th 2011 ] - Market Wire

Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States

[ Thu, Oct 13th 2011 ] - Market Wire

U.S. Sales of EGRIFTA(R) Driving Revenue Growth

[ Thu, Oct 13th 2011 ] - Market Wire

Los datos presentados durante el 5 Congreso trien .. or ECTRIMS y ACTRIMS demuestran el compromiso y l

[ Thu, Oct 13th 2011 ] - Market Wire

ISTA Pharmaceuticals Reports Results From the Sec .. URA(TM) Phase 3 Clinical Program for Dry Eye Dise

[ Thu, Oct 13th 2011 ] - Market Wire

China Medical Technologies Receives SFDA Approval .. ed KRAS Assay for Colorectal Cancer Targeted Drug

Wed, October 12, 2011

[ Wed, Oct 12th 2011 ] - Market Wire

Financial Statement 10/11

[ Wed, Oct 12th 2011 ] - Market Wire

Mylan Announces Intention to Refinance Existing Secured Credit Facility

[ Wed, Oct 12th 2011 ] - Market Wire

Dynavax to Host Analyst &;; Investor Day Webcast October 27, 2011

[ Wed, Oct 12th 2011 ] - Market Wire

Analyst View, Impact of Global Events - Research .. n Pharmaceuticals, Inc. and Trustmark Corporation

[ Wed, Oct 12th 2011 ] - Market Wire

Implant Sciences Receives Orders for the QS-B220 .. ench-Top Explosives and Narcotics Trace Detectors

[ Wed, Oct 12th 2011 ] - Market Wire

Ceapro Announces Signing of a Sales Agreement Wit .. s Inc. for its certified All-Natural Active Ingre

[ Wed, Oct 12th 2011 ] - Market Wire

OPKO Completes Sale of Ophthalmic Instrumentation Business

[ Wed, Oct 12th 2011 ] - Market Wire

Data Presented at the 5th Joint Triennial Congres .. nstrates Biogen Ideca?s Novel Science and Commitm

[ Wed, Oct 12th 2011 ] - Market Wire

Study Supports Use of Cambridge Hearta?s MTWA Test as Predictor of Sudden Cardiac Death

[ Wed, Oct 12th 2011 ] - Market Wire

SciClone Pharmaceuticals Announces Preliminary Settlement of Stockholder Derivative Litigation

[ Wed, Oct 12th 2011 ] - Market Wire

Illumina Announces Novel Human Exome Content Available on Multiple BeadChip Formats

Tue, October 11, 2011

[ Tue, Oct 11th 2011 ] - Market Wire

Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011

[ Tue, Oct 11th 2011 ] - Market Wire

Molina Healthcare of Missouri Receives aCommendablea? NCQA Status

[ Tue, Oct 11th 2011 ] - Market Wire

St. Jude Medical verbessert sein Patientenfernber .. gssystem durch mobile Benachrichtigungsfunktionen

[ Tue, Oct 11th 2011 ] - Market Wire

Healthnostics Launching MicroFill-2160 1st Quarter 2012

[ Tue, Oct 11th 2011 ] - Market Wire

GlycoMimetics and Pfizer Enter into Licensing Agr .. rently in Development to Treat Patients Experienc

[ Tue, Oct 11th 2011 ] - Market Wire

Glamsmile Opens Rome Studio, With the Wenzhou Studio Opening to Follow Shortly Thereafter

[ Tue, Oct 11th 2011 ] - Market Wire

International Stem Cell's Research Scientists Suc .. t Series of Preclinical Animal Trials of Neuronal

[ Tue, Oct 11th 2011 ] - Market Wire

BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review in Phase III Program

[ Tue, Oct 11th 2011 ] - Market Wire

Breakthrough in Multiple Sclerosis Achieved by FO .. IGHT MRI Announced at UC San Diego Medical Center

[ Tue, Oct 11th 2011 ] - Market Wire

Aetna??Michael Elliott???????

[ Tue, Oct 11th 2011 ] - Market Wire

Illumina Introduces Revolutionary Workflow Enhancements for MiSeqa"

Mon, October 10, 2011

[ Mon, Oct 10th 2011 ] - Market Wire

Electromed, Inc. Introduces aSeriously Pinka to Its SmartVest® Product Line

[ Mon, Oct 10th 2011 ] - Market Wire

Magellan Health Services Announces New Pharmacy Organization

[ Mon, Oct 10th 2011 ] - Market Wire

Health Net Receives Full URAC Accreditation for Disease Management

[ Mon, Oct 10th 2011 ] - Market Wire

Innovative Pipelines From Avanir and Cyclacel Pharmaceuticals Gain Momentum

[ Mon, Oct 10th 2011 ] - Market Wire

Equity Research on Humana Inc. and WellPoint Inc. - Obamacare Helping Several Health Insurers

[ Mon, Oct 10th 2011 ] - Market Wire

St. Jude Medical Advances Its Remote Patient Monitoring System with Mobile Notifications

[ Mon, Oct 10th 2011 ] - Market Wire

Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn®

[ Mon, Oct 10th 2011 ] - Market Wire

Natus Medical Announces Preliminary 2011 Third Quarter Revenue Results

[ Mon, Oct 10th 2011 ] - Market Wire

Medtronic Announces Results from TTOP-AF Trial De .. of Its Phased RF Ablation System in Treating Per

[ Mon, Oct 10th 2011 ] - Market Wire

PAREXEL and National University of Singapore Esta .. Meet Increasing Demand in Asia for Clinical Rese

[ Mon, Oct 10th 2011 ] - Market Wire

Inovio Pharmaceuticals and VGX International to A .. C and Hepatitis B Synthetic Vaccines into Clinica

Sun, October 9, 2011

[ Sun, Oct 09th 2011 ] - Market Wire

Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®

[ Sun, Oct 09th 2011 ] - Market Wire

Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar

Sat, October 8, 2011

[ Sat, Oct 08th 2011 ] - Market Wire

FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;;;;;; a Once-Daily Therap

[ Sat, Oct 08th 2011 ] - Market Wire

FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. Daily Therapy for Patients with Type 2 Diabetes W

[ Sat, Oct 08th 2011 ] - Market Wire

FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. 9;; a Once-Daily Therapy for Patients with

[ Sat, Oct 08th 2011 ] - Market Wire

FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;; a Once-Daily Therapy for Patients w

[ Sat, Oct 08th 2011 ] - Market Wire

FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. e-Daily Therapy for Patients with Type 2 Diabetes

[ Sat, Oct 08th 2011 ] - Market Wire

KCI Announces Proposed Offering of Senior Notes

[ Sat, Oct 08th 2011 ] - Market Wire

Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)

[ Sat, Oct 08th 2011 ] - Market Wire

West Increases Quarterly Dividend to $0.18

[ Sat, Oct 08th 2011 ] - Market Wire

Amerigroup Enhances Maternal Outreach Efforts

[ Sat, Oct 08th 2011 ] - Market Wire

IBM Launches University Competition to Combat Growth of Non-Communicable Diseases

Fri, October 7, 2011

[ Fri, Oct 07th 2011 ] - Market Wire

Celgene publica nueva informacin adicional sobre la conclusin del Artculo 20 para REVLIMID®

[ Fri, Oct 07th 2011 ] - Market Wire

NuVasive Completes Acquisition of Impulse Monitor .. and Conference Call of Third Quarter 2011 Results

[ Fri, Oct 07th 2011 ] - Market Wire

Law Offices of Howard G. Smith LLP Continues Inve .. ation of Pharmaceutical Product Development, Inc.

[ Fri, Oct 07th 2011 ] - Market Wire

MEDNAX 2011 Third Quarter Conference Call/Webcast Scheduled for Tuesday, November 1, 2011

[ Fri, Oct 07th 2011 ] - Market Wire

Vertex Announces the Date of its Third Quarter 2011 Financial Results Conference Call and Webcast

[ Fri, Oct 07th 2011 ] - Market Wire

Cardiovascular Systems Announces Preliminary First-Quarter Financial Results

[ Fri, Oct 07th 2011 ] - Market Wire

Analyst View, Impact of Global Events - Research .. n MELA Sciences, Inc. and SIGA Technologies, Inc.

[ Fri, Oct 07th 2011 ] - Market Wire

Expert's Economic Outlook, Global - Equity Resear .. harmaceutical Companies, Inc. and Targacept, Inc.

[ Fri, Oct 07th 2011 ] - Market Wire

Adherex Reports Meeting With FDA's Pediatric Subc .. gs Advisory Committee on the Development of Sodiu

[ Fri, Oct 07th 2011 ] - Market Wire

Senetek Announces Work Plans at Iron Creek Project

Thu, October 6, 2011

[ Thu, Oct 06th 2011 ] - Market Wire

Hansen Medical Announces Settlement of SEC Investigation

[ Thu, Oct 06th 2011 ] - Market Wire

Patient Home Monitoring Announces Unaudited Reven .. for September 2011, and Growth Figures for Q4 20

[ Thu, Oct 06th 2011 ] - Market Wire

Equity Research on Gilead Sciences Inc. and Human .. . - Regulatory Approval Key for Biotech Companies

[ Thu, Oct 06th 2011 ] - Market Wire

Peregrine Completes Patient Enrollment in Second- .. er Trial;; Data to Be Unblinded in First H

[ Thu, Oct 06th 2011 ] - Market Wire

Trimel Provides Update on Female Sexual Dysfunction "Anorgasmia" Clinical Program

[ Thu, Oct 06th 2011 ] - Market Wire

Novadaq Reports 165 System Shipments During Third Quarter 2011

[ Thu, Oct 06th 2011 ] - Market Wire

Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference

[ Thu, Oct 06th 2011 ] - Market Wire

Alexza and Grupo Ferrer Establish Partnership for .. uvea" (Staccato® Loxapine) in Europe and Latin A

[ Thu, Oct 06th 2011 ] - Market Wire

Greystone Logistics Announces Record Sales in 4th Quarter

[ Thu, Oct 06th 2011 ] - Market Wire

The Ensign Group Acquires La Jolla Skilled Nursing Facility

Wed, October 5, 2011

[ Wed, Oct 05th 2011 ] - Market Wire

Basilea receives request for extraordinary shareh .. lect additional members to the board of directors

[ Wed, Oct 05th 2011 ] - Market Wire

Waters Empowers Advantar Laboratories for Sustained Growth

[ Wed, Oct 05th 2011 ] - Market Wire

Investigational Oral Multiple Sclerosis Therapy T .. ignificantly Reduced Relapse Rate, Disability Pro

[ Wed, Oct 05th 2011 ] - Market Wire

MURRAY FRANK LLP Announces Investigation of Pharmaceutical Product Development, Inc.

[ Wed, Oct 05th 2011 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Investigation of DaVita, Inc.

[ Wed, Oct 05th 2011 ] - Market Wire

Voclosporin study published in the American Journal of Transplantation

[ Wed, Oct 05th 2011 ] - Market Wire

OncoSec Releases Devices for Use in Clinical Trials

[ Wed, Oct 05th 2011 ] - Market Wire

Inovio Pharmaceuticals' Synthetic Vaccine for Can .. ost Promising Research at Global Vaccine Congress

Tue, October 4, 2011

[ Tue, Oct 04th 2011 ] - Market Wire

Law Offices of Howard G. Smith LLP Announces Inve .. ation of Pharmaceutical Product Development, Inc.

[ Tue, Oct 04th 2011 ] - Market Wire

Bronstein, Gewirtz & Grossman, LLC Investigates DaVita, Inc.

[ Tue, Oct 04th 2011 ] - Market Wire

POZEN Provides Patent Litigation and Financial Guidance Update

[ Tue, Oct 04th 2011 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Pharmaceutical Product Development Inc.

[ Tue, Oct 04th 2011 ] - Market Wire

Ryan & Maniskas, LLP Announces Investigation of Pharmaceutical Product Development Inc.

[ Tue, Oct 04th 2011 ] - Market Wire

Neurocrine Biosciences Receives Second Milestone .. $20 Million Under Abbott Collaboration Agreement

[ Tue, Oct 04th 2011 ] - Market Wire

Investigation of Pharmaceutical Product Developme .. oldfarb Branham Law Firm LLP for Potential Shareh

[ Tue, Oct 04th 2011 ] - Market Wire

BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

[ Tue, Oct 04th 2011 ] - Market Wire

Initial Data from Bio-Path Holdingsa? Phase I Cli .. entation at American Society of Hematology Annual

Mon, October 3, 2011

[ Mon, Oct 03rd 2011 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Inve .. tion of Pharmaceuticals Product Development, Inc.

[ Mon, Oct 03rd 2011 ] - Market Wire

Por segundo ao consecutivo, el Humana Walmart-Pre .. a prima mensual ms baja en los 50 estados y en Wa

[ Mon, Oct 03rd 2011 ] - Market Wire

Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results

[ Mon, Oct 03rd 2011 ] - Market Wire

The Law Firm of Levi & Korsinsky, LLP Announces I .. ation of Pharmaceutical Product Development, Inc.

[ Mon, Oct 03rd 2011 ] - Market Wire

Tripp Levy PLLC Announces Investigation of Pharmaceutical Product Development

[ Mon, Oct 03rd 2011 ] - Market Wire

The Briscoe Law Firm and Powers Taylor, LLP Annou .. ation of Pharmaceutical Product Development, Inc.

[ Mon, Oct 03rd 2011 ] - Market Wire

Rigrodsky & Long, P.A. Announces Investigation of Pharmaceutical Product Development, Inc.

[ Mon, Oct 03rd 2011 ] - Market Wire

Medwell Capital to Adopt IFRS

[ Mon, Oct 03rd 2011 ] - Market Wire

IMRIS Announces Retirement of Chief Operating Officer

[ Mon, Oct 03rd 2011 ] - Market Wire

Allegiance Completes Private Placement Of 229,166 Common At $0.48 Per Share

Sun, October 2, 2011

[ Sun, Oct 02nd 2011 ] - Market Wire

HeartWare Reports Additional Clinical Data From B .. nued Access Patients at the 25th European Associa

Sat, October 1, 2011

[ Sat, Oct 01st 2011 ] - Market Wire

HealthSpring Unveils 2012 Medicare Advantage Plans

Fri, September 30, 2011

[ Fri, Sep 30th 2011 ] - Market Wire

Sangamo BioSciences to Host Conference Call to Di .. m Phase 2b Trial of SB-509 in Diabetic Neuropathy

[ Fri, Sep 30th 2011 ] - Market Wire

AxoGen, Inc. Announces Completion of Merger, Name Change and Executive Team Changes

[ Fri, Sep 30th 2011 ] - Market Wire

Health Management Associates, Inc. Completes the .. alth Partners from Catholic Health Partners, Inc.

[ Fri, Sep 30th 2011 ] - Market Wire

Merck Announces New Data Analyses for VICTRELISa" .. ed at The American Association for the Study of L

[ Fri, Sep 30th 2011 ] - Market Wire

Vertex to Present New Data from Hepatitis C Development Program at AASLD Annual Meeting

[ Fri, Sep 30th 2011 ] - Market Wire

Reminding Seniors to Be Mindful of Medications

[ Fri, Sep 30th 2011 ] - Market Wire

Merck to Hold Third-Quarter 2011 Sales and Earnings Conference Call on October 28

[ Fri, Sep 30th 2011 ] - Market Wire

A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer

[ Fri, Sep 30th 2011 ] - Market Wire

ShangPharma to Attend Upcoming Investor Conferences in October

[ Fri, Sep 30th 2011 ] - Market Wire

Concord Medical Services Announces Share Repurchase Program

Thu, September 29, 2011

[ Thu, Sep 29th 2011 ] - Market Wire

Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial

[ Thu, Sep 29th 2011 ] - Market Wire

Biogen Idec bevordert Tony Kingsley tot hoofd van Global Commercial Operations

[ Thu, Sep 29th 2011 ] - Market Wire

Aetna to Offer Individual Products to the National Association for the Self Employed

[ Thu, Sep 29th 2011 ] - Market Wire

Galectin Therapeutics Posts New Corporate Presentation Video to its Website

[ Thu, Sep 29th 2011 ] - Market Wire

SANUWAVE Appoints Private Equity Veteran Barbara M. Henagan to Its Board of Directors

[ Thu, Sep 29th 2011 ] - Market Wire

The National Association Of Boards Of Pharmacy An .. Patients About The Flood Of Counterfeit Medicines

[ Thu, Sep 29th 2011 ] - Market Wire

Federal Fire Department in Pearl Harbor Uses ZOLL .. ave 37-Year-Old Seaman from Sudden Cardiac Arrest

[ Thu, Sep 29th 2011 ] - Market Wire

NanoViricides Inc Files For Extension of Form 10-K Annual Report Submission Date

[ Thu, Sep 29th 2011 ] - Market Wire

Illumina Introduces Low-Cost Bovine BeadChip for Genotyping of Dairy Cattle

[ Thu, Sep 29th 2011 ] - Market Wire

Chronic Conditions Cost UK Economy More Than 20 Billion Pounds a Year

Wed, September 28, 2011

[ Wed, Sep 28th 2011 ] - Market Wire

Five Days Remain before Deadline in Class-action Lawsuit against Dendreon, Says Hagens Berman

[ Wed, Sep 28th 2011 ] - Market Wire

HeartWare Announces Presentation of Clinical Data .. tion for Cardio-Thoracic Surgery (EACTS) Annual M

[ Wed, Sep 28th 2011 ] - Market Wire

BioDelivery Sciences Announces Results from Phase .. cacy Study for BEMA Buprenorphine in Chronic Pain

[ Wed, Sep 28th 2011 ] - Market Wire

Experts to Provide Successful Strategies for Glob .. ent and Commercialization at PAREXEL Tokyo Semina

[ Wed, Sep 28th 2011 ] - Market Wire

Boston Scientific Announces Favorable Appellate C .. ming Non-Infringement of Johnson & Johnson Patent

[ Wed, Sep 28th 2011 ] - Market Wire

Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals

[ Wed, Sep 28th 2011 ] - Market Wire

IntegraMed Promotes Tim Sheehan to SVP and CFO

[ Wed, Sep 28th 2011 ] - Market Wire

ImmunoCellular Therapeuticsa? ICT-107 Recognized .. hovera?s Top 10 Most Licensable Oncology Products

[ Wed, Sep 28th 2011 ] - Market Wire

Amyris e Michelin Anunciam Colaborao para Desenvolver e Comercializar Isopreno de Fontes Renovveis

Tue, September 27, 2011

[ Tue, Sep 27th 2011 ] - Market Wire

Gallup und Healthways verffentlichen erste Ergebn .. s Well-Being (Wohlbefindens)-Index fr Deutschland

[ Tue, Sep 27th 2011 ] - Market Wire

HCA Announces Proposed Public Offering of $500 Million Senior Notes

[ Tue, Sep 27th 2011 ] - Market Wire

Catasys Launches Its Integrated Substance Dependence Program in Massachusetts

[ Tue, Sep 27th 2011 ] - Market Wire

Merck Names Cuong Viet Do as Chief Strategy Officer

[ Tue, Sep 27th 2011 ] - Market Wire

POZEN Announces October 4, 2011 Mid-Quarter Update and Financial Guidance Webcast

[ Tue, Sep 27th 2011 ] - Market Wire

BioLineRx to Present Data from the Successfully C .. L-1020 at European Conference on Schizophrenia Re

[ Tue, Sep 27th 2011 ] - Market Wire

Gallup, Healthways Release Inaugural Well-Being Index Results for Germany

[ Tue, Sep 27th 2011 ] - Market Wire

Molina Healthcare Names Michael Steele as Senior Vice President of Dual Eligible Strategies

[ Tue, Sep 27th 2011 ] - Market Wire

Alexion recibe opinin positiva del CHMP para Soli .. s con sndrome ur©mico hemoltico atpico (aHUS) en

[ Tue, Sep 27th 2011 ] - Market Wire

Evidence of AT13387 Activity in Gastrointestinal Stromal Tumor Models Presented at ECCO

Mon, September 26, 2011

[ Mon, Sep 26th 2011 ] - Market Wire

The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of American Medical Alert Corp.

[ Mon, Sep 26th 2011 ] - Market Wire

Guidance For Cannabis Science Brand Products To B .. lorado Based On Accumulating Anecdotal Reports Of

[ Mon, Sep 26th 2011 ] - Market Wire

Health Net Sponsors 2011 Congressional Medal of Honor Convention and Star-Studded Tribute Concert

[ Mon, Sep 26th 2011 ] - Market Wire

NPS Pharmaceuticals Appoints Eric Pauwels as Chief Commercial Officer

[ Mon, Sep 26th 2011 ] - Market Wire

Alnylam Initiates Phase I Clinical Study of ALN-P .. ting PCSK9 for the Treatment of Severe Hyperchole

[ Mon, Sep 26th 2011 ] - Market Wire

Synta Announces Presentation of Results of Ganete .. udy in Combination with Docetaxel in Solid Tumors

[ Mon, Sep 26th 2011 ] - Market Wire

iCo Therapeutics and JDRF Partner to Investigate iCo-007 in Diabetic Macular Edema

[ Mon, Sep 26th 2011 ] - Market Wire

ARIAD Announces Long-Term Follow Up of Patients w .. stant CML Treated with Ponatinib in Phase 1 Trial

[ Mon, Sep 26th 2011 ] - Market Wire

Millennium y Seattle Genetics presentan datos cln .. uximab Vedotin) en pacientes peditricos en reunin

[ Mon, Sep 26th 2011 ] - Market Wire

National Hospice and Palliative Care Expert Joins Amedisys

Sat, September 24, 2011

[ Sat, Sep 24th 2011 ] - Market Wire

FDA lsst Soliris® (Eculizumab) zur Behandlung al .. atypischem hmolytisch-urmischem Syndrom (aHUS) zu

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium en Seattle Genetics presenteren klinis .. brentuximab vedotin) bij pediatrische patinten op

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium et Seattle Genetics pr©sentent, la?oc .. de la?EMCC, des donn©es cliniques concernant la?

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium und Seattle Genetics legen auf der EMC .. n zu ADCETRISa" (Brentuximab Vedotin) bei pdiatri

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium et Seattle Genetics pr©sentent la?occ .. e la?EMCC des donn©es cliniques concernant la?ut

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium et Seattle Genetics pr©sentent, .. r©union annuelle de la?EMCC,;;; des

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium et Seattle Genetics pr©sentent, .. occasion de la r©union annuelle de la?EMCC,&#

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium and Seattle Genetics Present Clinical .. mab Vedotin) in Pediatric Patients at EMCC Annual

Fri, September 23, 2011

[ Fri, Sep 23rd 2011 ] - Market Wire

Il Comitato europeo per i prodotti medicinali per .. icinal Products for Human Use CHMP) adotta un par

[ Fri, Sep 23rd 2011 ] - Market Wire

Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc.

[ Fri, Sep 23rd 2011 ] - Market Wire

Soliris (eculizumab) goedgekeurd door FDA voor al .. met atypisch hemolytisch uremisch syndroom (aHUS)

[ Fri, Sep 23rd 2011 ] - Market Wire

Celgene: reglementaire update inzake REVLIMID

[ Fri, Sep 23rd 2011 ] - Market Wire

Glancy Binkow & Goldberg LLP Announces Investigation of American Medical Alert Corp.

[ Fri, Sep 23rd 2011 ] - Market Wire

European CHMP Adopts Positive Opinion for Evipler .. Tablet Regimen for the Treatment of HIV Infection

[ Fri, Sep 23rd 2011 ] - Market Wire

MISE JOUR RGLEMENTAIRE DE CELGENE AU SUJET DE REVLIMID®

[ Fri, Sep 23rd 2011 ] - Market Wire

Celgene prsentiert aktuelle Informationen zur Marktzulassung von REVLIMID®

[ Fri, Sep 23rd 2011 ] - Market Wire

AGGIORNAMENTO REGOLATORIO DI CELGENE CIRCA REVLIMID®

[ Fri, Sep 23rd 2011 ] - Market Wire

Celgene Regulatory Update on REVLIMID®

Thu, September 22, 2011

[ Thu, Sep 22nd 2011 ] - Market Wire

Covidien anuncia un aumento de dividendos del 12,5%

[ Thu, Sep 22nd 2011 ] - Market Wire

Enzon Announces Reduction in Force to Align Operations with Research and Development Activities

[ Thu, Sep 22nd 2011 ] - Market Wire

U.S. Physical Therapy to Present at the The Sixth Annual JMP Securities Healthcare Conference

[ Thu, Sep 22nd 2011 ] - Market Wire

Brain Resource Opens U.S. Headquarters in San Francisco

[ Thu, Sep 22nd 2011 ] - Market Wire

PFCD Hill Briefing Demonstrates How Health Indices Promote Prevention and Improve Overall Health

[ Thu, Sep 22nd 2011 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Dendreon Corporation

[ Thu, Sep 22nd 2011 ] - Market Wire

dermaPACE Pivotal Phase III Clinical Trial Data i .. r Healing to Be Presented at Plastic Surgery 2011

[ Thu, Sep 22nd 2011 ] - Market Wire

Cambridge Heart Announces Agreement to Distribute Its HearTwave II System in Singapore

[ Thu, Sep 22nd 2011 ] - Market Wire

Columbia Laboratories Extends Stockholder Rights .. rve Use of Net Operating Losses under Section 382

[ Thu, Sep 22nd 2011 ] - Market Wire

The Future of Ablation Therapies Conference

Wed, September 21, 2011

[ Wed, Sep 21st 2011 ] - Market Wire

Less Than Two Weeks Remain before Deadline in Cla .. tion Lawsuit against Dendreon, Says Hagens Berman

[ Wed, Sep 21st 2011 ] - Market Wire

Osiris Therapeutics to Present at the Sixth Annual JMP Securities Healthcare Conference

[ Wed, Sep 21st 2011 ] - Market Wire

Health Net Announces Appearance at Credit Suisse 2nd Annual Small & Mid Cap Conference

[ Wed, Sep 21st 2011 ] - Market Wire

Alnylam to Webcast Presentation at the JMP Securities Healthcare Conference

[ Wed, Sep 21st 2011 ] - Market Wire

Ironwood Pharmaceuticals to Present at Jefferies 2011 Global Healthcare Conference

[ Wed, Sep 21st 2011 ] - Market Wire

ACADIA Pharmaceuticals to Present at the Sixth An .. ities Healthcare Conference on September 28, 2011

[ Wed, Sep 21st 2011 ] - Market Wire

ARIAD Announces Start of Enrollment in Phase 1/2 .. 3, an Investigational Dual Inhibitor of ALK and E

[ Wed, Sep 21st 2011 ] - Market Wire

Celgene Corporation to Present at JMP Securities Healthcare Conference 2011

[ Wed, Sep 21st 2011 ] - Market Wire

Independent Proxy Advisory Firms ISS and Glass Le .. hareholders Vote in Favour of Plan of Arrangement

[ Wed, Sep 21st 2011 ] - Market Wire

Smith & Nephew Introduces New Hysteroscopic Morce .. on Simulator Designed to Enhance Surgeon Training

Tue, September 20, 2011

[ Tue, Sep 20th 2011 ] - Market Wire

Jury Awards Medtronic $101 Million in Patent Suit against NuVasive

[ Tue, Sep 20th 2011 ] - Market Wire

MedCath Announces O. Edwin French to Retire as Pr .. rker Will Become CEO, Lora Ramsey Will Become CFO

[ Tue, Sep 20th 2011 ] - Market Wire

Manny Villafaa Discusses FDA Update for Kips Bay Medical

[ Tue, Sep 20th 2011 ] - Market Wire

???????????????????????????????????

[ Tue, Sep 20th 2011 ] - Market Wire

St. Jude Medical meldt Europese introductie van kleiner quadripolair pacingsysteem

[ Tue, Sep 20th 2011 ] - Market Wire

Exactech Introduces New Material, Efficient Approach for Acetabular Reconstruction

The Law Firm of Levi & Korsinsky, LLP Announces Investigation of American Medical Alert Corp.

_{//health-fitness.news-articles.net/content/2011/ .. nvestigation-of-american-medical-alert-corp.html}
^{Published in Health and Fitness on Monday, October 3rd 2011 at 18:40 GMT by Market Wire}

NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of American Medical Alert Corp. (aAMACa or the aCompanya) (NASDAQ: AMAC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Tunstall Healthcare Group Limited. Under the terms of the transaction, AMAC shareholders will receive $8.55 per share of AMAC stock they own. AMAC shareholders will also receive one Contingent Payment Right per share in the event of a sale of AMACa�s interests in the Lifecomm joint venture or prior sale of Tunstall under certain conditions.

Click here to learn how to join the action: [ http://www.zlk.com/american-medical-alert-amac ], or call: 877-363-5972.

The investigation concerns whether the AMAC Board of Directors breached their fiduciary duties to AMAC stockholders by failing to adequately shop the Company before entering into this transaction and whether Tunstall Healthcare Group Limited is underpaying for AMAC shares, thus unlawfully harming AMAC stockholders.

If you own common stock in AMAC and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or [ http://www.zlk.com ].

Levi & Korsinsky is a national firm with offices in New York, California and Washington D.C. The firm has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire